Fox Chase Cancer Center clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 215 studies whose lead sponsor is Fox Chase Cancer Center. 30 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 14, 2026.
Keep track of what changes. Save the Fox Chase Cancer Center studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions Fox Chase Cancer Center leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 215. Browse all 215 →
- Blood Testing to Detect Cancer Recurrence in Patients With Early-Stage Non-Small Cell Lung CancerNot yet recruitingNCT07854769
- Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer PatientsRecruitingNCT05274048Phase 1
- Understanding the Preferences and Views of Older Adults on the Use of Geriatric and Objective Functional Assessments for Cancer Treatment Planning.RecruitingNCT06652347Not applicable
- Prehabilitation in High-risk Oncologic SurgeryRecruitingNCT07638410Not applicable
- Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial CarcinomaRecruitingNCT07043972Phase 2
- Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor TherapyRecruitingNCT07663422Phase 2
- Indirect Calorimetry-Guided Parenteral Nutrition Prescribing in Oncology PatientsRecruitingNCT07776704Not applicable
- Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine TumorsRecruitingNCT05263050Phase 2
- Communication About Sexual Health in Gynecologic CancerRecruitingNCT06904339Not applicable
- Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx CancerRecruitingNCT05800574Phase 2
- Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in MelanomaRecruitingNCT05498792Early Phase 1
- Iron Replacement to Reduce Anemia During Neoadjuvant ChemotherapyRecruitingNCT05800600Phase 2
- Dose Attenuated Chemotherapy in Compromised Patients With Lung CancerRecruitingNCT05800587Phase 2
- Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell CarcinomasRecruitingNCT07455032Phase 1
- Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial CarcinomaRecruitingNCT07221942Phase 2
- CARE Study: Cancer, Asian Americans, and Relationship EnrichmentRecruitingNCT06782581Not applicable
- Adaptive Radiation Boost for Rectal CancerRecruitingNCT07221058Phase 1
- Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)RecruitingNCT06396533
- Adaptive Radiation for Abdominopelvic MetastasesRecruitingNCT05880667Phase 1
- Adaptive Radiation for Locally Advanced Unresectable Pancreatic CancerRecruitingNCT06984562Not applicable
- Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate CancerRecruitingNCT07219303Not applicable
- Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced NeuropathyRecruitingNCT07167446Early Phase 1
- Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy.RecruitingNCT06914557Phase 2
- MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin LymphomaNot yet recruitingNCT06557330Phase 2
- Reducing Urban Cervical Cancer DisparitiesRecruitingNCT06416150Not applicable
- Genomic Risk in Retroperitoneal SarcomaRecruitingNCT06436846
- Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 InhibitionRecruitingNCT06218628Phase 1
- mychoiceTM Implementation With Medical Oncology PatientsRecruitingNCT06222242Not applicable
- Buprenorphine for Cancer PainRecruitingNCT05910190Phase 4
- Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal CancerRecruitingNCT03094884Phase 1
- Single Agent ONC201 in Recurrent or Metastatic Endometrial CancerTerminatedNCT03099499Phase 2
- Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)Active, not recruitingNCT05454280Phase 3
- A Phase I Safety and Pharmacokinetic Study of Gamitrinib Administered Intravenously to Patients With Advanced CancerSuspendedNCT04827810Phase 1
- Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the BladderActive, not recruitingNCT02968732Not applicable
- A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder CancerActive, not recruitingNCT04506554Phase 2
- HPV Self-sampling for Underscreened LatinasCompletedNCT06439706Not applicable
- Testing Gene PilotLX With Latinx Cancer PatientsActive, not recruitingNCT06476938Not applicable
- African Cancer Genome: GMDCompletedNCT05754658
- PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary CancerCompletedNCT02088775Not applicable
- Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLCActive, not recruitingNCT03786692Phase 2
- Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)Active, not recruitingNCT03114527Phase 2
- Pulse-low-dose Rate (PLDR) Radiation in Pancreatic CancerActive, not recruitingNCT04452357Not applicable
- Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)CompletedNCT02710734Phase 2
- Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLCActive, not recruitingNCT03527108Phase 2
- Phase I Study in Advanced Malignancies With 5-ALASuspendedNCT04381806Phase 1
- Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial CarcinomaActive, not recruitingNCT03291028
- Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast CancerActive, not recruitingNCT03125928Phase 2
- Organ Preservation in Early Rectal Cancer PatientsActive, not recruitingNCT03548961Phase 2
- PHL Treatment in Pancreatic CancerActive, not recruitingNCT05365893Early Phase 1
- Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell CarcinomaActive, not recruitingNCT03172754Phase 1/2